Literature DB >> 17917309

Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma.

Toru Tateno1, Hajime Izumiyama, Masaru Doi, Takumi Akashi, Kikuo Ohno, Yukio Hirata.   

Abstract

Silent corticotroph adenoma (SCA) is defined as an ACTH-producing pituitary tumor not associated with clinical and endocrine feartures of Cushing's syndrome, but its underlying molecular mechanism(s) remains unknown thus far. We tested the hypothesis that reduced expression of prohormone convertase (PC) 1/3 responsible for proteolytic processing of proopiomelanocortin (POMC) in SCA may lead to production of unprocessed, biologically inactive POMC and/or precursor of ACTH. Among 30 non-functioning pituitary macroadenomas (NFA) examined, we found 6 SCAs by immunohistochemical study using anti-ACTH antibody. Preoperative endocrine and diagnostic image tests did not reveal any differences between SCA and the remaining NFA except for the higher recurrence rate of SCA. While steady-state PC1/3 mRNA levels determined by RT-PCR were almost comparable between SCAs and NFAs, immunohistochemical study showed negative immunostaining for PC1/3 in all 6 SCAs. Our data suggest that defective PC1/3 expression may lead to preferential production of unprocessed, biologically inactive ACTH variants in SCA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917309     DOI: 10.1507/endocrj.k07-059

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  15 in total

1.  Negative correlation between tumour size and cortisol/ACTH ratios in patients with Cushing's disease harbouring microadenomas or macroadenomas.

Authors:  M C Machado; A E E Alcantara; A C L Pereira; V A S Cescato; N R Castro Musolino; B B de Mendonça; M D Bronstein; M C B V Fragoso
Journal:  J Endocrinol Invest       Date:  2016-06-30       Impact factor: 4.256

Review 2.  Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.

Authors:  Fabienne Langlois; Dawn Shao Ting Lim; Chris G Yedinak; Isabelle Cetas; Shirley McCartney; Justin Cetas; Aclan Dogan; Maria Fleseriu
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

3.  Perioperative hypothalamic pituitary adrenal function in patients with silent corticotroph adenomas.

Authors:  Abdelle F Cheres; Nadine ElAsmar; Aman Rajpal; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

Review 4.  Silent corticotroph adenomas.

Authors:  Odelia Cooper
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

5.  Processing of high-molecular-weight form adrenocorticotropin in human adrenocorticotropin-secreting tumor cell line (DMS-79) after transfection of prohormone convertase 1/3 gene.

Authors:  T Tateno; M Kato; Y Tani; T Yoshimoto; Y Oki; Y Hirata
Journal:  J Endocrinol Invest       Date:  2009-09-11       Impact factor: 4.256

Review 6.  Recent Understanding and Future Directions of Recurrent Corticotroph Tumors.

Authors:  José Miguel Hinojosa-Amaya; César Ernesto Lam-Chung; Daniel Cuevas-Ramos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 5.555

7.  Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas.

Authors:  Laura Sanchez-Tejada; Ruth Sanchez-Ortiga; Cristina Lamas; Rosa Camara; Pedro Riesgo; Carmen Fajardo; Francisco Ignacio Aranda; Antonio Pico
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 8.  Histopathological classification of non-functioning pituitary neuroendocrine tumors.

Authors:  Emilija Manojlovic-Gacic; Britt Edén Engström; Olivera Casar-Borota
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

9.  Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors.

Authors:  Araceli García-Martínez; Antonio C Fuentes-Fayos; Carmen Fajardo; Cristina Lamas; Rosa Cámara; Beatriz López-Muñoz; Ignacio Aranda; Raúl M Luque; Antonio Picó
Journal:  J Clin Med       Date:  2020-06-12       Impact factor: 4.241

Review 10.  Recent advances in understanding corticotroph pituitary tumor initiation and progression.

Authors:  Ulrich Renner; Denis Ciato; Günter K Stalla
Journal:  F1000Res       Date:  2018-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.